Cargando…

Investigation of the impact of SARS-CoV infection on the immunologic status and lung function after 15 years

BACKGROUND: We investigate the long-term effects of SARS-CoV on patients’ lung and immune systems 15 years post-infection. SARS-CoV-2 pandemic is ongoing however, another genetically related beta-coronavirus SARS-CoV caused an epidemic in 2003–2004. METHODS: We enrolled 58 healthcare workers from Pe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Jia, Zheng, Yali, Zhao, Lili, Yue, Zhihong, Pan, Feng, Chen, Yuehong, Yu, Bing, Chen, Yanwen, Zhao, Guangyu, Zhou, Yusen, Gao, Zhancheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8611627/ https://www.ncbi.nlm.nih.gov/pubmed/34819019 http://dx.doi.org/10.1186/s12879-021-06881-3

Ejemplares similares

Detection of Antibodies Against the SARS-CoV-2 Spike Protein and Analysis of the Peripheral Blood Mononuclear Cell Transcriptomic Profile, 15 Years After Recovery From SARS
por: Zhao, Lili, et al.
Publicado: (2021)

Potential therapeutic approaches for the early entry of SARS-CoV-2 by interrupting the interaction between the spike protein on SARS-CoV-2 and angiotensin-converting enzyme 2 (ACE2)
por: Xiang, Yusen, et al.
Publicado: (2021)

Antigenicity and immunogenicity of SARS-CoV S protein receptor-binding domain stably expressed in CHO cells
por: Du, Lanying, et al.
Publicado: (2009)

The immunologic status of newborns born to SARS-CoV-2–infected mothers in Wuhan, China
por: Liu, Pin, et al.
Publicado: (2020)

Receptor-binding domain of SARS-CoV spike protein induces long-term protective immunity in an animal model
por: Du, Lanying, et al.
Publicado: (2007)

Complement Receptor C5aR1 Inhibition Reduces Pyroptosis in hDPP4-Transgenic Mice Infected with MERS-CoV
por: Jiang, Yuting, et al.
Publicado: (2019)

Investigation of Animal Reservoir(s) of SARS-CoV
por: Hu, Zhihong, et al.
Publicado: (2008)

The altered immunological status of children conceived by assisted reproductive technology
por: Xu, Xin, et al.
Publicado: (2021)

Immunological Analysis of People in Northeast China after SARS-CoV-2 Inactivated Vaccine Injection
por: Fu, Yu, et al.
Publicado: (2021)

Blockade of the C5a–C5aR axis alleviates lung damage in hDPP4-transgenic mice infected with MERS-CoV
por: Jiang, Yuting, et al.
Publicado: (2018)

Rational Design of Zika Virus Subunit Vaccine with Enhanced Efficacy
por: Tai, Wanbo, et al.
Publicado: (2019)

Priming with rAAV encoding RBD of SARS-CoV S protein and boosting with RBD-specific peptides for T cell epitopes elevated humoral and cellular immune responses against SARS-CoV infection
por: Du, Lanying, et al.
Publicado: (2008)

A Truncated Receptor-Binding Domain of MERS-CoV Spike Protein Potently Inhibits MERS-CoV Infection and Induces Strong Neutralizing Antibody Responses: Implication for Developing Therapeutics and Vaccines
por: Du, Lanying, et al.
Publicado: (2013)

Correction: A Truncated Receptor-Binding Domain of MERS-CoV Spike Protein Potently Inhibits MERS-CoV Infection and Induces Strong Neutralizing Antibody Responses: Implication for Developing Therapeutics and Vaccines
por: Du, Lanying, et al.
Publicado: (2022)

Immunological evaluation of an inactivated SARS-CoV-2 vaccine in rhesus macaques
por: Chen, Hongbo, et al.
Publicado: (2021)

Immunological and Genetic Investigation of SARS-CoV-2 Reinfection in an Otherwise Healthy, Young Marine Recruit
por: Letizia, Andrew G., et al.
Publicado: (2021)

Enhanced Ability of Oligomeric Nanobodies Targeting MERS Coronavirus Receptor-Binding Domain
por: He, Lei, et al.
Publicado: (2019)

Recombinant receptor-binding domain of SARS-CoV spike protein expressed in mammalian, insect and E. coli cells elicits potent neutralizing antibody and protective immunity
por: Du, Lanying, et al.
Publicado: (2009)

The M Protein of SARS-CoV: Basic Structural and Immunological Properties
por: Hu, Yongwu, et al.
Publicado: (2003)

The immunology of SARS-CoV-2 infections and vaccines
por: Grigoryan, Lilit, et al.
Publicado: (2020)

Immunology of SARS-CoV-2 infections and vaccines
por: Schenten, Dominik, et al.
Publicado: (2021)

Antibodies, epicenter of SARS-CoV-2 immunology
por: Pecetta, Simone, et al.
Publicado: (2021)

Insights into the virologic and immunologic features of SARS-COV-2
por: Polat, Ceylan, et al.
Publicado: (2021)

Immunology of SARS-CoV-2 infection and vaccination
por: Lin, Baoxu, et al.
Publicado: (2023)

A Novel Nanobody Targeting Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Receptor-Binding Domain Has Potent Cross-Neutralizing Activity and Protective Efficacy against MERS-CoV
por: Zhao, Guangyu, et al.
Publicado: (2018)

Epidemiological and immunological features of obesity and SARS-CoV-2
por: Nilles, Eric J, et al.
Publicado: (2020)

Epidemiological and Immunological Features of Obesity and SARS-CoV-2
por: Nilles, Eric J., et al.
Publicado: (2021)

Comprehensive Humoral and Cellular Immune Responses to SARS-CoV-2 Variants in Diverse Chinese Population
por: Li, Jiwei, et al.
Publicado: (2022)

Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2
por: Zhou, Guangyu, et al.
Publicado: (2020)

Understanding the Immunologic Characteristics of Neurologic Manifestations of SARS-CoV-2 and Potential Immunological Mechanisms
por: Mohammadi, Soheil, et al.
Publicado: (2020)

Corrigendum to “Comprehensive Humoral and Cellular Immune Responses to SARS-CoV-2 Variants in Diverse Chinese Population”
por: Li, Jiwei, et al.
Publicado: (2022)

Intranasal vaccination with recombinant receptor-binding domain of MERS-CoV spike protein induces much stronger local mucosal immune responses than subcutaneous immunization: Implication for designing novel mucosal MERS vaccines
por: Ma, Cuiqing, et al.
Publicado: (2014)

A novel human mAb (MERS-GD27) provides prophylactic and postexposure efficacy in MERS-CoV susceptible mice
por: Niu, Peihua, et al.
Publicado: (2018)

Lipid profiles and differential lipids in serum related to severity of community-acquired pneumonia: A pilot study
por: Chen, Li, et al.
Publicado: (2021)

Deciphering SARS-CoV-2 Virologic and Immunologic Features
por: Lebeau, Grégorie, et al.
Publicado: (2020)

Clinical and Immunological Assessment of Patients with Sars-Cov-2 Infections
por: Singh, Aditi, et al.
Publicado: (2021)

SARS-CoV-2: Immunopeptidomics and Other Immunological Studies
por: Chavda, Vivek P., et al.
Publicado: (2022)

Structure-Based Virtual Screening and Identification of Potential Inhibitors of SARS-CoV-2 S-RBD and ACE2 Interaction
por: Xiong, Jiacheng, et al.
Publicado: (2021)

Immunological Study of Combined Administration of SARS-CoV-2 DNA Vaccine and Inactivated Vaccine
por: Meng, Ziyan, et al.
Publicado: (2022)

Immunological investigation of a multiepitope peptide vaccine candidate based on main proteins of SARS-CoV-2 pathogen
por: Khairkhah, Niloofar, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ov5092rlaj6qrd3sfk4eq9fape